A New Twist On Non-Invasive Cancer Detection: Breath, Owlstone Medical Reveals

There are many companies developing non-invasive liquid biopsies for cancer, including genomics giant Illumina.

But Owlstone Medical is taking a different route, working on a breath-based cancer detection system. The company hopes their technology will improve early detection and decrease false positives. They have recently expanded their Lung Cancer Indicator Detection (LuCID) trial, and will recruit around 3,000 patients to validate the technology.

Back to news